Bond Gilead Medica 5.65% ( US375558AS26 ) in USD
Issuer | Gilead Medica |
Market price | ![]() |
Country | ![]() |
ISIN code |
![]() |
Interest rate | 5.65% per year ( payment 2 times a year) |
Maturity | 01/12/2041 |
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
Minimal amount | 2 000 USD |
Total amount | 1 000 000 000 USD |
Cusip | 375558AS2 |
Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) |
Moody's rating | A3 ( Upper medium grade - Investment-grade ) |
Next Coupon | 01/12/2025 ( In 115 days ) |
Detailed description |
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology. The Bond issued by Gilead Medica ( United States ) , in USD, with the ISIN code US375558AS26, pays a coupon of 5.65% per year. The coupons are paid 2 times per year and the Bond maturity is 01/12/2041 The Bond issued by Gilead Medica ( United States ) , in USD, with the ISIN code US375558AS26, was rated A3 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Gilead Medica ( United States ) , in USD, with the ISIN code US375558AS26, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |